Aurobindo Pharma Careers

Aurobindo Pharma Corporate Film Founded in 1986 by Mr. P.V. Ramprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born of a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry. Aurobindo Pharma became a public company in 1992 and listed its shares on the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillin’s, Aurobindo Pharma has a presence in key therapeutic segments such as neurosciences (CNS), cardiovascular (CVS), anti-retroviral, anti-diabetics, gastroenterology and Anti-biotics Through cost effective manufacturing capabilities and a few loyal customers, the company also entered the high margin specialty generic formulations segment. Today Aurobindo Pharma has evolved into a knowledge driven company manufacturing active pharmaceutical ingredients and formulation products. It is R&D focused and has a multi-product portfolio with manufacturing facilities in several countries. Aurobindo Pharma Foundation Aurobindo Pharma Foundation CSR 2020 Committed to Quality and Safety !Company photos Blurred background !Company photos The Company’s R&D strengths are in developing intellectual property in non-infringing processes and resolving complex chemistry challenges. Aurobindo Pharma is in the process of developing new drug delivery systems, new dosage formulations, and applying new technology for better processes. The R&D Center, in Hyderabad covers over 13,000 sq.m and provides a nurturing environment to a multi-disciplinary team of over 700 scientists striving for excellence. The Centre meets cGLP requirements and is focused on organic synthesis, analytical research, dosage form development, pharmacology, bio-equivalence studies, and drug delivery systems.